Copyright
©The Author(s) 2024.
World J Transplant. Dec 18, 2024; 14(4): 98718
Published online Dec 18, 2024. doi: 10.5500/wjt.v14.i4.98718
Published online Dec 18, 2024. doi: 10.5500/wjt.v14.i4.98718
Figure 1 Indication for liver transplantation over time.
MASLD: Metabolic dysfunction-associated steatotic liver disease; HCV: Hepatitis C virus; ALD: Alcohol-associated liver disease; LT: Liver transplantation; HCC: Hepatocellular carcinoma.
- Citation: Sato-Espinoza K, Chotiprasidhi P, Liza E, Placido-Damian Z, Diaz-Ferrer J. Evolution of liver transplantation in the metabolic dysfunction-associated steatotic liver disease era: Tracking impact through time. World J Transplant 2024; 14(4): 98718
- URL: https://www.wjgnet.com/2220-3230/full/v14/i4/98718.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i4.98718